M.P. Lorenzo

Dr. M.P. Lorenzo

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2017 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Open access
DDDanuta Dudzik
Danuta Dudzik
MZMarcin Zorawski
Marcin Zorawski
MSMariusz Skotnicki
Mariusz Skotnicki
WZWieslaw Zarzycki
Wieslaw Zarzycki
AGAntonia García
Antonia García
MRM.Pilar Ramos-Alvarez
M.Pilar Ramos-Alvarez
Gestational Diabetes Mellitus (GDM) causes severe short- and long-term complications for the mother, fetus and neonate, including type 2-diabetes (T2DM) later in life. In this pilot study, GC-Q/MS analysis was applied for plasma metabolomics fingerprinting of 24 healthy and 24 women with GDM at different stages of gestation (second and third trimester) and postpartum (one and three months). Multivariate (unsupervised and supervised) statistical analysis was performed to investigate variance in the data, identify outliers and for unbiased assessment of data quality. Plasma fingerprints allowed for the discrimination of GDM pregnant women from controls both in the 2nd and 3rd trimesters of gestation. However, metabolic profiles tended to be similar after delivery. Follow up of these women revealed that 4 of them developed T2DM within 2 years postpartum. Multivariate PLS-DA models limited to women with GDM showed clear separation 3 months postpartum. In the 2nd trimester of gestation there was also a clear separation between GDM women that were normoglycemic after pregnancy and those with recognized postpartum T2DM. Metabolites that had the strongest discriminative power between these groups in the 2nd trimester of gestation were 2-hydroxybutyrate, 3-hydroxybutyrate, and stearic acid. We have described, that early GDM comprises metabotypes that are associated with the risk of future complications, including postpartum T2DM. In this pilot study, we provide evidence that 2-hydroxybutyrate and 3-hydroxybutyrate may be considered as future prognostic biomarkers to predict the onset of diabetic complications in women with gestational diabetes after delivery.

20 June 2021 in Foods
Verified
Journal Article
Open access
PDF file
CSCristina Sánchez
Cristina Sánchez
Cristina A. FenteCristina A. Fente
Cristina A. Fente
Patricia RegalPatricia Regal
Patricia Regal
Alexandre LamasAlexandre Lamas
Alexandre Lamas
MLM.P. Lorenzo
M.P. Lorenzo
Human milk oligosaccharides (HMOs) are the third most abundant solid component of breast milk. However, the newborn cannot assimilate them as nutrients. They are recognized prebiotic agents (the first in the newborn diet) that stimulate the growth of beneficial microorganisms, mainly the genus Bifidobacterium, dominant in the gut of breastfed infants. The structures of the oligosaccharides vary mainly according to maternal genetics, but also other maternal factors such as parity and mode of delivery, age, diet, and nutritional status or even geographic location and seasonality cause different breast milk oligosaccharides profiles. Differences in the profiles of HMO have been linked to breast milk microbiota and gut microbial colonization of babies. Here, we provide a review of the scope of reports on associations between HMOs and the infant gut microbiota to assess the impact of HMO composition.

14 May 2022 in BMC Chemistry
Verified
Journal Article
Open access
PDF file
EAELENA ALBA ALVARO ALONSO
ELENA ALBA ALVARO ALONSO
MLM.P. Lorenzo
M.P. Lorenzo
IEIsmael Escobar-Rodríguez
Ismael Escobar-Rodríguez
AAAntonio Aguilar-Ros
Antonio Aguilar-Ros
Purpose: The Pharmacy Service of the Infanta Leonor University Hospital acquires, compounds, distributes and dispenses more than 3000 L of methadone oral solution to Drug Addiction Patients Centers per year. Our purpose is to develop and validate an improved high performance liquid chromatography (HPLC) method to quantify methadone hydrochloride in a new oral solution with methylhydroxybenzoate (methylparaben) and propylhydroxybenzoate (propylparaben) to be implemented in physicochemical stability studies that allow to provide more information and even to increase the beyond-use date. Methods: A HPLC-Agilent® 1100 equipment, comprising a quaternary pump and an ultraviolet diode-array-detector (DAD) was used. An analytical method development and validation was completed. The curve was constructed from methadone working concentrations of 75–125% (7.5, 9.0, 10.0, 11.0 and 12.5 mg/mL) to assess the linear relationship between the concentration of the analyte and the obtained areas. Precision and accuracy were calculated. Detection and quantification limit (LD, LQ) were estimated using the EURACHEM method. Forced-degradation studies were also performed. Results: Chromatographic conditions were: flow rate 1.6 mL/min; mobile phase 55% acetonitrile and 45% sodium phosphate 25 mM (pH = 10); injection volume was 5 µL. The column was a Waters-XTerra™ RP18, maintained at 40 °C. DAD was λ = 254 nm. Retention times for methadone, methylparaben and propylparaben were 4.34, 0.70 and 0.88 min respectively. The method was linear (y = 284.3x − 97.8, r = 0.996). Instrumental precision was 0.33% for standards (n = 10); intra-assay precision 0.53% (n = 6) and inter-assay precision 1.95% (n = 12). The relative standard deviation percentage for accuracy was 1.28%. The recovery percentage was 101.5 ± 1.5%. LQ and LD were 2.18 µg/mL and 2.0 µg/mL respectively. The most destabilizing conditions were oxidizing and alkaline. The chromatograms confirmed no interference with the methadone signal. Conclusions: The HPLC method has proved to be valid and reproducible for methadone quantification in a new oral solution with methylparaben and propylparaben. This assay is a rapid, simple and reliable technique that can be used in daily analysis and physicochemical stability studies.

28 April 2022 in Molecules
Verified
Journal Article
Open access
PDF file
EAELENA ALBA ALVARO ALONSO
ELENA ALBA ALVARO ALONSO
MLM.P. Lorenzo
M.P. Lorenzo
AGAndrea Gonzalez-Prieto
Andrea Gonzalez-Prieto
EIElsa Izquierdo-García
Elsa Izquierdo-García
IEIsmael Escobar-Rodríguez
Ismael Escobar-Rodríguez
AAAntonio Aguilar-Ros
Antonio Aguilar-Ros
In this article, we studied physicochemical and microbiological stability and determined the beyond-use date of two oral solutions of methadone in three storage conditions. For this, two oral solutions of methadone (10 mg/mL) were prepared, with and without parabens, as preservatives. They were packed in amber glass vials kept unopened until the day of the test, and in a multi-dose umber glass bottle opened daily. They were stored at 5 ± 3 °C, 25 ± 2 °C and 40 ± 2 °C. pH, clarity, and organoleptic characteristics were obtained. A stability-indicating high-performance liquid chromatography method was used to determine methadone. Microbiological quality was studied and antimicrobial effectiveness testing was also determined following European Pharmacopoeia guidelines. Samples were analyzed at days 0, 7, 14, 21, 28, 42, 56, 70, and 91 in triplicate. After 91 days of storage, pH remained stable at about 6.5–7 in the two solutions, ensuring no risk of methadone precipitation. The organoleptic characteristics remained stable (colorless, odorless, and bitter taste). The absence of particles was confirmed. No differences were found with the use of preservatives. Methadone concentration remained within 95–105% in all samples. No microbial growth was observed. Hence, the two oral methadone solutions were physically and microbiologically stable at 5 ± 3 °C, 25 ± 2 °C, and 40 ± 2 °C for 91 days in closed and opened amber glass bottles.

30 January 2011 in Revista ALCONPAT
Verified
Journal Article
Open access
PDF file
SGS. Goñi
S. Goñi
ANA GUERREROANA GUERRERO
ANA GUERRERO
AMA. Macías
A. Macías
MLM.P. Lorenzo
M.P. Lorenzo
Debido a la magnitud del problema que representa el volumen de los residuos generados tanto por el desarrollo industrial como por el tecnológico, las investigaciones a escala mundial se están volcando en minimizar los impactos medioambientales que producen. En el presente trabajo, se dará una especial mención a los residuos procedentes de la incineración de residuos sólidos urbanos (RSU), que independientemente del sistema de incineración que se haya llevado a cabo, suponen un gran número de cenizas y escorias, que pueden ser valorizadas, o en su defecto, estabilizadas, de manera que reduzcan su impacto medioambiental. Entre las acciones que se están llevando a cabo para conseguir la minimización de estos residuos se encuentra, la valorización mediante su uso como materia prima secundaria o alternativa en la fabricación de cementos. Por todo ello, el objetivo del trabajo que nuestro grupo de investigación presenta a continuación, está basado en la síntesis de “cementos ecoeficientes” o “amigables” con el medio ambiente, en los que se ha empleado como materia prima secundaria, ceniza volante procedente de la incineración de residuos sólidos urbanos (CVIRSU). El innovador proceso de fabricación de estos cementos, supone un avance importante para el desarrollo sostenible de la industria, concretamente, la industria cementera. Este proceso implica una rebaja de la temperatura de clinkerización (< 1100ºC) y una minimización de las emisiones de CO2.

16 June 2026 in Cells
Verified
Journal Article
Open access
PDF file
JVJuan Vicente-Valor
Juan Vicente-Valor
STSofia Elena Tesolato
Sofia Elena Tesolato
MLM.P. Lorenzo
M.P. Lorenzo
SSSofia de la Serna
Sofia de la Serna
IDInmaculada Domínguez-Serrano
Inmaculada Domínguez-Serrano
PIPilar Iniesta
Pilar Iniesta
Gut microbiota-derived short-chain fatty acids (SCFAs) shape epithelial and immune homeostasis, yet systemic SCFA profiles may diverge from gut microbial composition due to absorption and host metabolism. We quantified fasting serum SCFAs in 36 surgically resected colorectal cancer (CRC) patients and 20 cancer-free controls using targeted high-performance liquid chromatography–triple quadrupole mass spectrometry, and integrated these data with fecal and serum bacterial DNA profiles generated by 16S ribosomal RNA sequencing and functional inference. CRC was associated with a distinct circulating SCFA pattern: total SCFAs and acetate were increased, branched SCFAs were higher, and butyrate and valerate were lower relative to controls. Despite this clear systemic signature, associations between serum SCFAs and the relative abundance (RA) of putative SCFA-producing genera were sparse and inconsistent across CRC and control groups, both when considering fecal producers and serum-detected taxa. Interestingly, the total RA of SCFA-producing genera was higher in controls in feces but higher in CRC in serum, further supporting compartment-specific decoupling. Finally, several circulating SCFAs showed inverse associations with indicators of tumor progression within CRC. These results motivate integrative microbiota–metabolite studies and validation in larger cohorts to clarify how circulating SCFAs relate to gastrointestinal disease biology and immune regulation.